Five-year follow-up study of tardive dyskinesia. 1985

G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk

A 5-year follow-up investigation of TD was carried out in 85 Hungarian schizophrenic out-patients. No substantial changes occurred during the 5 years in pharmacotherapy: most patients continued on neuroleptics and antiparkinson drugs. Comparison of 1978 and 1983 ratings revealed increased dyskinesia scores, which was statistically significant on the DRS Choreo-athetosis cluster. There was an increase in the number of patients with "moderately" severe TD from 4 in 1978 to 6 in 1981 to 10 (9 "Moderate" and 1 "Severe" TD) in 1983. The total number of TD cases as defined by research diagnostic criteria increased by only 3. The long-term trend in these neuroleptic-treated schizophrenics is for dyskinesia to plateau after reaching mild intensity, while in a minority of cases, the dyskinesia tends to extend from the oro-facial region to other body regions.

UI MeSH Term Description Entries
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
January 1986, Psychopharmacology bulletin,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
October 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
December 1977, Journal of the American Geriatrics Society,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
November 1984, Psychosomatics,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
February 1983, Psychological medicine,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
October 1992, Acta psychiatrica Scandinavica,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
October 1983, The British journal of psychiatry : the journal of mental science,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
February 1990, Acta psychiatrica Scandinavica,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
June 1995, The Journal of nervous and mental disease,
G Gardos, and J O Cole, and A Perenyi, and D E Casey, and I Samu, and M Kallos, and S Schniebolk
March 1982, The American journal of psychiatry,
Copied contents to your clipboard!